Angiogenesis: a year in review.
作者信息
Griffioen Arjan W, Dudley Andrew C
机构信息
Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Department of Microbiology, Immunology, and Cancer Biology, The University of Virginia, & The Emily Couric Cancer Center, Charlottesville, VA, 22908, USA.
出版信息
Angiogenesis. 2021 May;24(2):195-196. doi: 10.1007/s10456-021-09798-2.
Abstract
摘要
相似文献
1
Angiogenesis: a year in review.血管生成：年度回顾
Angiogenesis. 2021 May;24(2):195-196. doi: 10.1007/s10456-021-09798-2.
2
Endothelial heterogeneity and plasticity.内皮细胞的异质性与可塑性。
Angiogenesis. 2021 May;24(2):197-198. doi: 10.1007/s10456-021-09794-6.
3
[Mechanisms and factors of angiogenesis].[血管生成的机制与因素]
Usp Fiziol Nauk. 2010 Apr-Jun;41(2):68-89.
4
John Hunter and the origin of the term "angiogenesis".约翰·亨特与“血管生成”一词的起源。
Angiogenesis. 2016 Apr;19(2):255-6. doi: 10.1007/s10456-016-9496-7. Epub 2016 Feb 3.
5
The endothelium in vascular pharmacology--an overview of 2011-2012.
Vascul Pharmacol. 2013 May-Jun;58(5-6):335-6. doi: 10.1016/j.vph.2013.03.003. Epub 2013 Apr 6.
6
Introduction to the ECR special angiogenesis issue.ECR 特刊：血管生成介绍
Exp Cell Res. 2013 May 15;319(9):1239. doi: 10.1016/j.yexcr.2013.03.014. Epub 2013 Mar 15.
7
[Angiogenesis, anti-angiogenesis].[血管生成，抗血管生成]
Orv Hetil. 1998 May 17;139(20):1269.
8
Angiogenesis: protein, gene, or cell therapy?
Heart Surg Forum. 2001;4(4):301-4.
9
[Physiologic and neoplastic angiogenesis].
J Chir (Paris). 2008 Jan;145 Spec No 1:1S4-7.
10
Progress towards a unifying hypothesis for angiogenesis.血管生成统一假说的进展。
J Clin Invest. 1996 Mar 15;97(6):1359. doi: 10.1172/JCI118554.
引用本文的文献
1
Neutrophil extracellular traps in tumor progression of gynecologic cancers.中性粒细胞胞外诱捕网在妇科恶性肿瘤进展中的作用
Front Immunol. 2024 Nov 1;15:1421889. doi: 10.3389/fimmu.2024.1421889. eCollection 2024.
2
Variations of VEGFR2 Chemical Space: Stimulator and Inhibitory Peptides.VEGFR2 化学空间的变化：刺激肽和抑制肽。
Int J Mol Sci. 2024 Jul 16;25(14):7787. doi: 10.3390/ijms25147787.
3
The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB.中性粒细胞胞外诱捕网的支架通过 ITGAV/NFκB 促进 CCA 进展并调节血管生成。
Cell Commun Signal. 2024 Feb 8;22(1):103. doi: 10.1186/s12964-024-01500-5.
4
Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets.布魯斯胺 D 和那可丁抑制乳腺癌細胞的增殖及潛在藥物靶點的預測。
PLoS One. 2024 Jan 12;19(1):e0297203. doi: 10.1371/journal.pone.0297203. eCollection 2024.
5
Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis.血管内皮生长因子 A（VEGF-A）抑制：银屑病的有效治疗策略。
Int J Mol Sci. 2023 Dec 20;25(1):59. doi: 10.3390/ijms25010059.
6
The modes of angiogenesis: an updated perspective.血管生成的模式：一个更新的视角。
Angiogenesis. 2023 Nov;26(4):477-480. doi: 10.1007/s10456-023-09895-4. Epub 2023 Aug 28.
7
The Role of GAB1 in Cancer.GAB1在癌症中的作用。
Cancers (Basel). 2023 Aug 20;15(16):4179. doi: 10.3390/cancers15164179.
8
The dual role of microRNA (miR)-20b in cancers: Friend or foe?微小 RNA（miR）-20b 在癌症中的双重作用：是敌是友？
Cell Commun Signal. 2023 Jan 30;21(1):26. doi: 10.1186/s12964-022-01019-7.
9
Activity of Melatonin Against Gastric Cancer Growth in a Chick Embryo Tumor Xenograft Model.褪黑素对鸡胚肿瘤异种移植模型中胃癌生长的作用
Cancer Manag Res. 2021 Nov 24;13:8803-8808. doi: 10.2147/CMAR.S329728. eCollection 2021.
本文引用的文献
1
Endothelial heterogeneity and plasticity.内皮细胞的异质性与可塑性。
Angiogenesis. 2021 May;24(2):197-198. doi: 10.1007/s10456-021-09794-6.
2
Microvascular dysfunction in COVID-19: the MYSTIC study.新型冠状病毒肺炎中的微血管功能障碍：MYSTIC 研究。
Angiogenesis. 2021 Feb;24(1):145-157. doi: 10.1007/s10456-020-09753-7. Epub 2020 Oct 14.
3
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.血管生成素-2 作为内皮细胞激活的标志物，是预测 COVID-19 患者入住重症监护病房的良好预测因子。
Angiogenesis. 2020 Nov;23(4):611-620. doi: 10.1007/s10456-020-09730-0. Epub 2020 May 27.
4
COVID-19: the vasculature unleashed.COVID-19：血管失控。
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
5
New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury.线粒体在心肌微血管缺血/再灌注损伤中的作用的新见解。
Angiogenesis. 2020 Aug;23(3):299-314. doi: 10.1007/s10456-020-09720-2. Epub 2020 Apr 3.
6
Vessel co-option and resistance to anti-angiogenic therapy.血管生成拟态与抗血管生成治疗抵抗。
Angiogenesis. 2020 Feb;23(1):55-74. doi: 10.1007/s10456-019-09698-6. Epub 2019 Dec 21.
7
Introduction to special issue: vascular co-option in cancer.特刊介绍：癌症中的血管共选择
Angiogenesis. 2020 Feb;23(1):1-2. doi: 10.1007/s10456-019-09699-5.
8
Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread.血管趋向性、周细胞拟态和血管外迁移性转移：肿瘤扩散的胚胎发生衍生程序。
Angiogenesis. 2020 Feb;23(1):27-41. doi: 10.1007/s10456-019-09695-9. Epub 2019 Nov 12.
9
Vessel co-option in glioblastoma: emerging insights and opportunities.血管生成拟态在胶质母细胞瘤中的作用：新的认识和机遇。
Angiogenesis. 2020 Feb;23(1):9-16. doi: 10.1007/s10456-019-09691-z. Epub 2019 Nov 2.
10
Pathological features of vessel co-option versus sprouting angiogenesis.血管生成拟态与血管发芽的病理特征。
Angiogenesis. 2020 Feb;23(1):43-54. doi: 10.1007/s10456-019-09690-0. Epub 2019 Oct 26.
Zotero 插件